Establishment of anti-mesothelioma monoclonal antibodies

BACKGROUND: Mesotheliomas are aggressive, therapy-resistant tumors that are predicted to increase in incidence at least until 2020. The prognosis of patients with mesothelioma is generally poor because they are typically diagnosed at a late stage and their tumors are resistant to current conventiona...

Descripción completa

Detalles Bibliográficos
Autores principales: Mizutani, Natsuko, Abe, Masaaki, Matsuoka, Shuji, Kajino, Kazunori, Wakiya, Midori, Ohtsuji, Naomi, Hatano, Ryo, Morimoto, Chikao, Hino, Okio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4921032/
https://www.ncbi.nlm.nih.gov/pubmed/27342200
http://dx.doi.org/10.1186/s13104-016-2128-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4921032/
https://www.ncbi.nlm.nih.gov/pubmed/27342200
http://dx.doi.org/10.1186/s13104-016-2128-x

Ejemplares similares